Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies.

Schorr, Christopher; Forindez, Jorge; Espinoza-Gutarra, Manuel; Mehta, Rakesh; Grover, Natalie; Perna, Fabiana

Schorr, Christopher; Forindez, Jorge; Espinoza-Gutarra, Manuel; Mehta, Rakesh; Grover, Natalie; Perna, Fabiana.

Afiliación

Schorr C; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Forindez J; Department of Biomedical Engineering, Purdue University, West Lafayette, IN 47907, USA.
Espinoza-Gutarra M; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
Mehta R; O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham, AL 35233, USA.
Grover N; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Perna F; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.

Int J Mol Sci ; 24(9)2023 May 06.

Article en En | MEDLINE | ID: mdl-37176053

Asunto(s)

Receptores Quiméricos de Antígenos; Trombosis; Humanos; Adulto; Inmunoterapia Adoptiva/efectos adversos; Estudios Retrospectivos; Linfocitos T; Trombosis/etiología; Receptores de Antígenos de Linfocitos T/genética

Palabras clave

chimeric antigen receptor (CAR) T-cell; cytokine release syndrome (CRS); disseminated intravascular coagulation (DIC); hematological malignancies; immune effector cell-associated neurotoxicity syndrome (ICANS); multiple myeloma; non-Hodgkin lymphoma (NHL); thrombotic events; toxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Trombosis / Receptores Quiméricos de Antígenos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google